Algernon Health Inc.
AGNPF
$0.04
$0.0011.05%
OTC PK
| 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -4.02% | 50.74% | -51.07% | -5.25% | -56.05% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -9.68% | 19.16% | -67.07% | -30.37% | -61.18% |
| Operating Income | 9.68% | -19.16% | 67.07% | 30.37% | 61.18% |
| Income Before Tax | 9.85% | -139.15% | 65.19% | 27.49% | 83.77% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 9.85% | -139.15% | 65.19% | 27.49% | 83.77% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 9.85% | -139.15% | 65.19% | 27.49% | 83.77% |
| EBIT | 9.68% | -19.16% | 67.07% | 30.37% | 61.18% |
| EBITDA | 17.58% | -18.90% | 67.39% | 30.41% | 61.19% |
| EPS Basic | 38.64% | -129.42% | 75.58% | 58.26% | 78.88% |
| Normalized Basic EPS | 37.80% | 9.18% | 75.31% | 58.28% | 46.05% |
| EPS Diluted | 38.64% | -132.50% | 75.58% | 58.26% | 79.05% |
| Normalized Diluted EPS | 37.80% | 9.18% | 75.31% | 58.28% | 46.05% |
| Average Basic Shares Outstanding | 46.62% | 33.34% | 42.07% | 73.06% | -22.93% |
| Average Diluted Shares Outstanding | 46.62% | 33.34% | 42.07% | 73.06% | -22.93% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |